FDA Warnings on Fraudulent COVID-19 Products

FDA recently issued two warnings letters jointly with the Federal Trade Commission to companies selling unapproved and misbranded products as drugs for use in treating or preventing COVID-19.Consumers concerned about COVID-19 should consult with their health care provider. FDA issued the following:

• Warning letter to Lakpura LLC for selling unapproved and misbranded products as drugs for use in treating or preventing COVID-19. 
• Warning Letter to Bespoke Apothecary LLC for selling unapproved and misbranded COVID kit and Post Virus Recovery Herbal Tea products as drugs for use in treating or preventing COVID-19. 

FDA is actively monitoring for any firms marketing products with fraudulent COVID-19 prevention and treatment claims.

Fraudulent COVID-19 Products